M. tuberculosis infections are responsible for more than 1 million deaths per year. Developing effective strategies to combat this disease requires a greater understanding of M. tuberculosis biology. As in all cells, protein quality control is essential for the viability of M. tuberculosis, which likely faces proteotoxic stress within a host. Here, we identify an M. tuberculosis protein, Ruc, that gains chaperone activity upon oxidation. Ruc represents a previously unrecognized family of redox-regulated chaperones found throughout the bacterial superkingdom. Additionally, we found that oxidized Ruc promotes the protein-folding activity of the essential M. tuberculosis Hsp70 chaperone system. This work contributes to a growing body of evidence that oxidative stress provides a particular strain on cellular protein stability.
KEYWORDS: Hsp70, Mycobacterium, chaperone, protein, proteostasis, tuberculosis
ABSTRACT
The bacterial pathogen Mycobacterium tuberculosis is the leading cause of death by an infectious disease among humans. Here, we describe a previously uncharacterized M. tuberculosis protein, Rv0991c, as a molecular chaperone that is activated by oxidation. Rv0991c has homologs in most bacterial lineages and appears to function analogously to the well-characterized Escherichia coli redox-regulated chaperone Hsp33, despite a dissimilar protein sequence. Rv0991c is transcriptionally coregulated with hsp60 and hsp70 chaperone genes in M. tuberculosis, suggesting that Rv0991c functions with these chaperones in maintaining protein quality control. Supporting this hypothesis, we found that, like oxidized Hsp33, oxidized Rv0991c prevents the aggregation of a model unfolded protein in vitro and promotes its refolding by the M. tuberculosis Hsp70 chaperone system. Furthermore, Rv0991c interacts with DnaK and can associate with many other M. tuberculosis proteins. We therefore propose that Rv0991c, which we named “Ruc” (redox-regulated protein with unstructured C terminus), represents a founding member of a new chaperone family that protects M. tuberculosis and other species from proteotoxicity during oxidative stress.
INTRODUCTION
The folding of a protein that is in a nonnative conformation, including during translation or upon stress-induced denaturation, can be accomplished in all organisms by a set of chaperones belonging to the Hsp70 and Hsp40 protein families. In bacteria, these chaperones are called DnaK and DnaJ, respectively (reviewed in reference 1). DnaK is an ATPase that iteratively binds to and releases protein substrates, allowing them to fold into a native conformation. In the ATP-bound state, DnaK has a low substrate affinity. Engagement of DnaK with a substrate induces ATP hydrolysis in a DnaJ-dependent manner, resulting in an ADP-bound DnaK-substrate complex. Finally, replacement of ADP with ATP results in release of the client protein, which has either reached its native structure or can rebind to DnaK (2, 3). This cycle of high- and low-affinity substrate-binding states is facilitated by a nucleotide exchange factor, known in bacteria as GrpE (4). Besides harboring intrinsic protein-folding activity, the DnaK/DnaJ/GrpE system (DnaKJE) can also deliver substrates to GroEL/GroES chaperonins (also known as Hsp60/Hsp10) (5, 6), and prokaryotic and eukaryotic DnaKJE homologs can cooperate with proteases to promote the degradation of unfolded substrates (7, 8).
Proteins in nonnative conformations often expose hydrophobic regions that are prone to aggregation, an event that is toxic to cells. Importantly, aggregate formation becomes irreversible if DnaKJE cannot access unfolded proteins for refolding. To remedy this situation, the Hsp100 family of ATP-dependent chaperones (called ClpB in bacteria) cooperate with DnaKJE by solubilizing proteins within aggregates (9–11). The prevention of irreversible protein aggregation is also accomplished in all organisms by the small heat shock protein (sHsp) family of chaperones. Rather than actively dissociating protein aggregates by ATP hydrolysis, sHsps act by simply binding to denatured or misfolded proteins; the presence of sHsps within protein aggregates allows for efficient refolding by ATPase chaperones (5, 12–15). Thus, in contrast to “refoldases,” sHsps are “holdases” that afford cells the ability to rapidly respond to proteotoxic stress in an energy-independent manner.
While DnaKJE, chaperonins, ClpB, and sHsps are all active under steady-state conditions, there are also noncanonical chaperones that only become active upon encountering specific stresses. Hsp33 (encoded by hslO), found in both prokaryotes and eukaryotes, and the eukaryotic Get3 are inactive as chaperones in the normal reducing environment of the cytoplasm; however, oxidation of cysteine thiols within Hsp33 or Get3 induces conformational changes that allow them to bind to unfolded proteins (6, 16–19). Hsp33 prevents the irreversible aggregation of unfolded proteins by delivering substrates to ATPase chaperones for refolding after stress is alleviated (6). In Escherichia coli, this activity is of particular importance during oxidative stress, during which low ATP levels can cause DnaK to enter a partially unfolded, nucleotide-depleted state; the presence of Hsp33 allows for refolding by DnaKJE to proceed once a normal temperature and reducing environment are restored (20). Two other bacterial chaperones, RidA and CnoX, are activated by the oxidant hypochlorous acid through a mechanism that does not involve oxidation of cysteine thiols but, rather, chlorination of free amino groups (21, 22). Aside from oxidation, other noncanonical chaperones have been found to activate upon exposure to high temperatures or acid (reviewed in reference 23).
The bacterial pathogen Mycobacterium tuberculosis is currently responsible for the majority of human infectious disease-related deaths worldwide (24). In this work, we describe our discovery that the uncharacterized M. tuberculosis gene Rv0991c encodes a chaperone, which we named Ruc (redox-regulated chaperone with unstructured C terminus). Ruc belongs to a previously unacknowledged but evolutionarily widespread family of bacterial proteins with little predicted structural similarity to other chaperones. Upon oxidation, Ruc is capable of inhibiting protein aggregation and can promote the refolding of unfolded proteins by DnaKJE. Ruc was also found to interact with DnaK in M. tuberculosis; however, despite its association with this essential protein-folding chaperone, Ruc did not have a strong role for M. tuberculosis virulence in mice and was not required for bacterial survival during in vitro oxidative stress under several conditions tested. Taken together, these observations suggest that Ruc is important for the ability of M. tuberculosis and many other bacterial species to withstand oxidation-associated proteotoxicity under to-be-determined conditions.
RESULTS
Ruc induction during heat stress requires the M. tuberculosis Pup-proteasome system.
We became interested in Ruc after identifying the transcriptional repressor HrcA as a putative target of the M. tuberculosis Pup-proteasome system (25). In M. tuberculosis, HrcA directly represses four genes; three of them encode highly conserved chaperone proteins of the Hsp60/Hsp10 family, while the fourth gene, ruc, encodes a protein of unknown function (26). In addition to its negative regulation by HrcA, ruc is induced during heat stress by SigH, a sigma factor that also activates transcription of the Hsp70/Hsp40 genes (27). The DNA sequences to which SigH and HrcA bind upstream of the ruc start codon overlap, suggesting that these two transcriptional regulators compete for binding to the ruc promoter (Fig. 1A). We compared Ruc abundance upon incubation of M. tuberculosis at 37°C or 45°C and found that Ruc levels increased dramatically at 45°C, consistent with previously reported transcriptional data (Fig. 1B, lanes 1 and 2; see Table 1 for strains) (26). The low abundance of Ruc at 37°C is primarily due to repression by HrcA, given that Ruc was highly abundant in an hrcA mutant at this temperature (Fig. 1B, lane 5). We observed a further induction of Ruc levels during heat shock in an hrcA mutant (Fig. 1B, lane 6). These results corroborate earlier evidence that ruc expression is controlled in two ways: through repression by HrcA and induction by SigH.
TABLE 1.
Strain, plasmid, or primer | Relevant genotype, description, or sequence | Source or reference no. |
---|---|---|
M. tuberculosis strain | ||
MHD1 | Wild-type H37Rv | ATCC 25618 |
MHD1383 | Hygr; ΔhrcA::hyg | 25 |
MHD1384 | Hygr; Δruc::hyg (deletion-disruption mutation of Rv0991c) | 25 |
MHD149 | Hygr; Δmpa::hyg | 61 |
MHD1541 | Hygr; H37Rv, pOLYG-ruc-TAP | This study |
MHD1385 | Kanr; H37Rv, pMV306kan | This study |
MHD1393 | Kanr, Hygr; MHD1384, pMV306kan | This study |
MHD1394 | Kanr, Hygr; MHD1384, pMV306kan-ruc | This study |
E. coli strain | ||
DH5α | supE44 ΔλacU169 (φ80 lacZΔM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 (Nalr) | Gibco |
ER2566 | F-λ-fhuA2 (lon) ompT lacZ::T7 geneI gal sulA11 Δ(mcrC-mrr)114::IS10 R(mcr-73::miniTn10)2 R(zgb-210::Tn10)1 (tetS) endA1 (dcm) | 72 |
BL21(DE3) | F– ompT gal dcm lon hsdSB(rB−mB–) λ(DE3 [lacI lacUV5-T7p07 ind1 sam7 nin5] (malB+)K-12(λS) | New England Biolabs |
Plasmid | ||
pET24b(+) | Kanr; for inducible production of recombinant protein in E. coli | Novagen |
pET24b(+)-Rv0991c-his6 | Kanr; for production of recombinant Ruc with C-terminal His6 (Ruc-His6) | This study |
pAJD107 | Ampr; contains multiple restriction sites for cloning | 73 |
pAJD107-Rv0991c | Ampr; for making the ruc expression vector | This study |
pAJD107-Rv0991c-C8SC11S | Ampr; for cloning HisSUMO-ruc-C8SC11S expression vector | This study |
pET24b(+)-Rv0991c | Kanr; for production of recombinant, native Ruc | This study |
pET24b(+)-Ruc-C8,11S | Kanr; for cloning `HisSUMO-ruc-C8SC11S expression vector | This study |
pEcTL02 | Ampr; for purification of M. tuberculosis ClpB with N-terminal His6-SUMO from E. coli | 12 |
pEcTL04 | Ampr; for purification of M. tuberculosis DnaJ2 with N-terminal His6-SUMO from E. coli | 12 |
pEcTL05 | Ampr; for purification of M. tuberculosis GrpE with N-terminal His6-SUMO from E. coli | 12 |
pEcTL06 | Ampr; for purification of M. tuberculosis DnaK with N-terminal His6-SUMO from E. coli | 12 |
pET24b(+)-HisSUMO-ruc | Kanr; for purification of M. tuberculosis Ruc with N-terminal His6-SUMO from E. coli | This study |
pET24b(+)-HisSUMO-ruc-Nterm | Kanr; for purification of M. tuberculosis RucNterm (amino acids 1 through 49) with N-terminal His6-SUMO from E. coli | This study |
pET24b(+)-HisSUMO-ruc-C8SC11S | Kanr; for purification of M. tuberculosis RucC8S,C11S (containing cysteine to serine substitutions in residues 8 and 11) with N-terminal His6-SUMO from E. coli | This study |
pET24b(+)-HisSUMO-ruc-C29S,C32S | Kanr; for purification of M. tuberculosis RucC29S,C32S (containing cysteine to serine substitutions in residues 29 and 32) with N-terminal His6-SUMO from E. coli | This study |
pHYRS52 | Ampr; for purification of SUMO protease (S. cerevisiae Ulp1, amino acids 403 to 621) with N-terminal His6 from E. coli | Addgene |
pOLYG | Hygr; for overproduction of proteins in M. tuberculosis | 74 |
pOLYG-Rv0991c-TAP | Hygr; for purification of Ruc with C-terminal hexahistidine-FLAG tandem affinity purification tag from M. tuberculosis | This study |
pMV306kan | Kanr; for integration into the L5 attB site of the M. tuberculosis chromosome | 75 |
pMV306kan-Rv0991c | Kanr; ruc complementation plasmid | This study |
Primer | ||
NdeI-Rv0991c-F | gatcCATATGccaacctacagctacgagtgcacc | |
HindIII-Rv0991c-R | gtagAAGCTTgacggccgcggcggcg | |
HindIII-Rv0991c-F | gtagAAGCTTtcgtctagtcgcggtggtgcg | |
XbaI-Rv0991c-R | ttatTCTAGAtcagacggccgcggcgg | |
XbaI-Rv0991c-TAP-R | gatcTCTAGAtcagtggtggtggtggtggtgctcgagtgcggccgccttatcgtcgtcatccttgtaatcgacggccgcggcggcggttgtgga | |
BglII-Rv0991c-R | tagacAGATCTtcagacggccgcggcggcggttgt | |
SUMO-Ruc-soeR | ctcgtagctgtaggttggcaccccaccaatctgttctctgtgagcctc | |
SUMO-Ruc-soeF | gaggctcacagagaacagattggtggggtgccaacctacagctacgag | |
Ruc-KpnI-R | tataGGTACCtcagacggccgcggcggcggttgt | |
RucNterm-KpnI-R | tataGGTACCtcagcctttgaacaccacgccgaccgc | |
NdeI-Rv0991c-C8SC11S-F | GCGCCATATGCCAACCTACAGCTACGAGAGCACCCAGAGCGCCAACCGCTTCGATGTTGTG | |
Rv0991c-C29SC32S-F | CCGACGATGCGCTGACCACGAGCGAGCGGAGTTCTGGCCGGCTGCGCAAGCTGTTC | |
Rv0991c-C29SC32S-R | GAACAGCTTGCGCAGCCGGCCAGAACTCCGCTCGCTCGTGGTCAGCGCATCGTCGG | |
T7-F | taatacgactcactataggg | |
T7-term | GCTAGTTATTGCTCAGCGG |
In a recent study, we proposed that the pupylation and degradation of HrcA by the M. tuberculosis proteasome is required for the full expression of the HrcA regulon. We previously reported the abundance of HrcA-regulated gene products between a wild-type (WT) M. tuberculosis strain and an mpa mutant, which cannot degrade pupylated proteins, and found that GroES, GroEL1, and GroEL2 levels are significantly lower in an mpa strain; however, Ruc abundance is unaffected by disruption of mpa under these conditions. This result suggested that proteasomal degradation of HrcA is not sufficient for Ruc production under the conditions tested (25); however, this experiment was performed with cultures incubated at 37°C in minimal medium. We therefore compared Ruc abundance from the same strains incubated at 45°C and observed a striking defect in Ruc production in the mpa mutant (Fig. 1C, lane 2). This result supports the hypothesis that the proteasomal degradation of HrcA is required for M. tuberculosis to robustly induce ruc expression during heat stress.
A ruc null mutant does not have a strong virulence defect in C57BL/6J mice.
Previous studies have shown that M. tuberculosis protein quality control pathways are important for its pathogenesis. M. tuberculosis strains deficient in clpB or the sHsp-encoding acr2 have impaired virulence in mice (28, 29), while a mutant lacking HspR, which represses the expression of clpB, acr2, and the hsp70/hsp40 genes, also produces less severe infections (30). Because ruc is coregulated with essential chaperones, we tested if Ruc was required for the full virulence of M. tuberculosis by inoculating C57BL/6J mice with our M. tuberculosis strains by aerosol and assessing bacterial burden in the lungs and spleens at several time points following infection. We performed the entire experiment twice and combined the data from both sets of infections. In the lungs, a ruc mutant had a subtle growth defect compared to the WT and complemented strains, however, this phenotype was not statistically significant at most time points (P > 0.05) (Fig. 1D, top). Furthermore, we observed no differences in survival among the strains in the spleens (Fig. 1D, bottom). Based on these data, we concluded that Ruc does not play an essential role for M. tuberculosis virulence in this mouse infection model.
Ruc is part of a novel protein family found across the bacterial superkingdom.
According to the mycobacterial genome database MycoBrowser, Ruc is conserved in both pathogenic and nonpathogenic mycobacteria (31). To determine the broader phyletic distribution of Ruc among bacteria, we searched the Ruc protein sequence against a curated collection of 7,423 complete prokaryotic genomes. Ruc is highly conserved throughout the Planctomycetes, Chloroflexi, Deltaproteobacteria and Betaproteobacteria, Actinobacteria, Spirochaetes, and Verrucomicrobia lineages; additionally, Ruc is found in species within other major bacterial lineages such as Gammaproteobacteria, Firmicutes, and Cyanobacteria. This phyletic pattern suggests that Ruc was present in the last bacterial common ancestor, with rare lateral transfers to archaea (Table 2).
TABLE 2.
Phylum (no. of genomes) | % genomes with ruc |
---|---|
Bacteria | |
Gammaproteobacteria (923) | 26.65 |
Betaproteobacteria (333) | 82.88 |
Zetaproteobacteria (5) | 80 |
Alphaproteobacteria (469) | 17.27 |
Deltaproteobacteria (86) | 86.05 |
Proteobacteria (43) | 74.42 |
Thermodesulfobacteria (4) | 100 |
Spirochaetes (70) | 48.57 |
Deferribacteres (4) | 100 |
Chrysiogenetes (1) | 100 |
Nitrospirae (73) | 86.3 |
Acidobacteria (9) | 100 |
Elusimicrobia (3) | 33.33 |
Verrucomicrobia (74) | 60.81 |
Chlamydiae (43) | 6.98 |
Planctomycetes (18) | 100 |
Bacteroidetes (263) | 1.9 |
Chlorobi (263) | 5.7 |
Fibrobacteres (2) | 0 |
Gemmatimonadetes (3) | 100 |
Ignavibacteriae (2) | 100 |
Aquificae (15) | 20 |
Dictyoglomi (2) | 100 |
Thermotogae (29) | 100 |
Deinococcus-Thermus (26) | 100 |
Synergistetes (5) | 0 |
Fusobacteria (16) | 0 |
Thermobaculum (1) | 100 |
Actinobacteria (497) | 73.84 |
Chloroflexi (22) | 100 |
Armatimonadetes (15) | 73.33 |
Tenericutes (124) | 0 |
Firmicutes (772) | 8.94 |
Cyanobacteria (127) | 13.39 |
Calditrichaeota (2) | 100 |
Unclassified (2,565) | 11.89 |
Archaea | |
Crenarchaeota (61) | 1.64 |
Euryarchaeota (187) | 6.42 |
Archaea (31) | 3.23 |
To define the conserved features of Ruc, we used Phyre2, a program that predicts secondary and tertiary protein structures based on published sequences and solved structures (32). Alignment of Ruc with its homologs in other bacteria identified two conserved domains. The amino (N)-terminal region, consisting of approximately 50 amino acids, contains four cysteine (Cys) residues arranged in a manner consistent with a zinc ribbon fold, a domain found in zinc-binding proteins of highly diverse functions (Fig. 2A) (33). The carboxyl (C)-terminal regions of Ruc homologs consist of highly variable sequences of amino acids ranging in length from approximately 7 to 61 residues. While these C-terminal domains do not share significant similarity at the protein sequence level, they appear to be uniformly composed of hydrophilic residues with no predicted secondary structure. Overall, these structural predictions allowed us to conclude that M. tuberculosis Ruc and its homologs are likely characterized by a metal-coordinating N-terminal domain and a disordered C terminus (Fig. 2B).
Having established that ruc is coexpressed with the Hsp60 and Hsp70 chaperone system genes in M. tuberculosis and is present in diverse bacterial lineages, we next asked if ruc is associated with protein quality control genes in other species. A comprehensive gene neighborhood analysis among bacteria recovered widespread associations with chaperone genes, as well as transcription factors and proteases that regulate chaperone production. In 32% of the PVC (Planctomycetes, Verrucomicrobia, and Chlamydiae) and in 21% of the FCB (Fibrobacteres, Chlorobi, and Bacteroidetes) bacterial superphyla, ruc is present in loci encoding DnaK, DnaJ, GrpE, ClpB, alpha-crystallin sHsps (Acr), and HrcA. In bacteria from the Chloroflexi and Gemmatimonadetes phyla, as well as in several unclassified species, ruc is additionally associated with genes encoding GroES/GroEL chaperonins, the chaperone-regulating membrane protease FtsH, and the redox-regulated chaperone RidA (Fig. 2C). The identification of these conserved genetic linkages across a wide variety of phyla, as well as the observation that ruc is transcriptionally coregulated with essential chaperone genes in M. tuberculosis, strongly suggested that Ruc performs a function related to protein folding.
Ruc coordinates zinc and is an intrinsically disordered protein.
Based on the observations that ruc is closely associated with essential chaperone genes and that Ruc contains putative zinc-coordinating cysteines, we hypothesized that Ruc has oxidation-dependent chaperone activity. Hsp33 and Get3, two well-characterized redox regulated chaperones, each contain a zinc-coordinating domain consisting of four cysteines. Under oxidizing conditions, these cysteines form intramolecular disulfide bonds and release zinc, allowing these chaperones to form complexes with denatured proteins to prevent their irreversible aggregation (16, 18, 34).
To begin to test Ruc chaperone activity using in vitro assays, we produced and purified M. tuberculosis Ruc from E. coli under reducing conditions (Rucred). We oxidized purified Ruc (Rucox) by incubation with hydrogen peroxide (H2O2) and copper chloride (CuCl2), which react to generate hydroxyl radicals that rapidly oxidize cysteines (35). On an SDS-PAGE gel, Rucred migrated as a single band (Fig. 3A, lane 1), while Rucox migrated through the gel as multiple species whose sizes were consistent with the formation of covalent, intermolecular disulfide bonds (Fig. 3A, lane 2). Treatment of Rucox with the thiol-reducing agent dithiothreitol (DTT) resulted in a significant loss of higher-molecular-weight species, indicating that the oxidation of Ruc cysteines is reversible (Fig. 3A, lane 3). These results demonstrate that Ruc cysteines form disulfide bonds under oxidizing conditions to create covalently linked multimers.
In Hsp33, four conserved cysteines coordinate zinc. This zinc binding maintains Hsp33 in an inactive state yet allows Hsp33 to become readily activated once an oxidant is present (34). To determine if Ruc binds zinc using its four cysteines, we used 4-(2-pyridylazo)resorcinol (PAR), a chemical that chelates free zinc to yield an absorbance peak at 500 nm (A500) (see Materials and Methods). Incubation of either Rucred or Rucox with PAR alone did not yield a significant change in A500, demonstrating that the protein preparations contained little free zinc; however, addition of N-ethylmaleimide (NEM), which forms adducts on cysteine thiols, resulted in the release of zinc from Rucred that could be detected in approximately equimolar abundance to Rucred. Meanwhile, addition of NEM to Rucox did not reveal any change in zinc levels (Fig. 3B). These data suggest that under reducing conditions, Ruc cysteines coordinate an atom of zinc and that this binding is disrupted when the cysteine thiols are oxidized.
Given that PAR can chelate metals in addition to zinc (36), we next determined the precise identity of the metal bound to Ruc using inductively coupled plasma mass spectrometry (ICP-MS). In this analysis, we found zinc was present in Rucred preparations in close to equimolar amounts; when Rucred was treated with NEM prior to ICP-MS, little Ruc-bound zinc was detected (Table S1). Taken together, our metal-binding assays demonstrated that cysteine thiols in Ruc coordinate a single zinc atom.
Aside from the N-terminal zinc ribbon fold domain, the entire C-terminal half of Ruc was predicted to lack secondary structure (Fig. 2B). To evaluate the degree of disorder in Ruc, we measured the secondary structures found in Rucred and Rucox using circular dichroism (CD) spectroscopy (reviewed in reference 37). In accordance with structural predictions, both Rucred and Rucox yielded a CD spectrum characteristic of disordered proteins (Fig. 3C) (38).
Oxidized Ruc prevents unfolded protein aggregation in vitro.
Chaperones are able to inhibit protein aggregation due to their propensity to bind to unfolded proteins. A common method for detecting chaperone activity uses purified firefly luciferase, which denatures and forms irreversible aggregates when heated above 42°C; the presence of a chaperone during denaturation of luciferase prevents its aggregation (16, 39). We therefore used this method to test chaperone activity by Ruc. When we incubated luciferase at 45°C, we observed the formation of precipitates that could be detected by an increase in light absorbance at 350 nm. In the presence of a 5-fold molar excess of Rucred, we observed a similar level of luciferase aggregation, demonstrating that Rucred has little to no chaperone activity. In contrast, the presence of Rucox during heat inactivation, either in excess or at an equimolar concentration, significantly inhibited luciferase aggregation (Fig. 4A). When we measured luciferase aggregation using a different method of detection, light scattering (40), we also observed the inhibition of aggregation by Rucox but not by Rucred (Fig. S1A). Furthermore, chaperone activity by Ruc was observed when Ruc was pretreated with the oxidizing agents hypochlorite or nitric oxide (Fig. S1B), further supporting a model whereby oxidized Ruc counteracts protein aggregation. Importantly, Ruc was also activated by NEM (Fig. S1C), which prevents disulfide bond formation, demonstrating that the generation of covalently linked Ruc multimers during oxidation (Fig. 3A) is not formally required for Ruc chaperone activity and may be an in vitro artifact.
The high degree of disorder present in Ruc, along with our previous observation that all Ruc homologs are predicted to harbor domains that lack secondary structure, supports a hypothesis whereby the unstructured C-terminal domain somehow contributes to the function of this protein. In the activation process of Hsp33, oxidation induces conformational changes that expose a disordered region with a high affinity for client proteins (41, 42). We therefore asked if the intrinsically disordered C-terminal domain of Ruc was required for its chaperone activity. We produced a truncated Ruc variant, RucNterm (amino acids 1 through 49), which harbors only the zinc-binding motif (Fig. 4B, lane 2). In contrast to the variety of multimers observed for Rucox, oxidized RucNterm (RucNterm-ox) formed a single high-molecular-weight species (Fig. 4B, compare lanes 3 and 4). When we tested the chaperone activity of oxidized RucNterm (RucNterm-ox), we found that it was unable to prevent luciferase aggregation (Fig. 4C). Thus, the disordered C terminus of Ruc is required for its chaperone activity, either by binding to client protein, by influencing the conformation or oligomerization state of Ruc, or through a combination of factors.
We next asked if replacing the Ruc cysteines, which we predicted would disrupt zinc coordination, would allow for constitutive Ruc activity in the absence of oxidation, a phenomenon that is observed for Hsp33 (34). We made cysteine-to-serine (C-S) substitutions in Ruc, generating RucC8S,C11S and RucC29S,C32S (see Table 1 for primers and plasmids). Neither RucC8S,C11S-red nor RucC29S,C32S-red were bound to zinc upon their purification (Fig. 4D). When we tested the ability of each reduced Ruc variant to inhibit luciferase aggregation, we found that both exhibited significant chaperone activity compared to wild-type Rucred (Fig. 4E). Collectively, these results support a model by which Ruc is in a zinc-bound, inactive state under reducing conditions and that oxidation and zinc release promotes a conformation of Ruc that allows for its interaction with an unfolded protein.
Oxidized Ruc promotes protein refolding by M. tuberculosis Hsp70/Hsp40 chaperones.
Non-ATPase bacterial chaperones such as Hsp33 and sHsps prevent irreversible protein aggregation in vivo; critically, this function relies on the ability of ATP-dependent chaperones to eventually refold substrates that are bound by these non-ATPase chaperones (5, 6, 43). To further understand the potential role of Ruc in M. tuberculosis protein quality control, we tested if Ruc could promote protein refolding by M. tuberculosis DnaKJE. To test this hypothesis, we heated luciferase either alone or in the presence of Rucred or Rucox; after bringing the reaction to room temperature and adding purified M. tuberculosis DnaK, DnaJ2, and GrpE under reducing conditions, we monitored refolding by measuring luciferase activity over time. Only minimal refolding of luciferase by DnaKJE was observed when luciferase was denatured in the absence of a chaperone, a result that was expected based on previous studies (5, 6, 12, 43). In contrast, significant DnaKJE-mediated refolding of luciferase was achieved when luciferase was denatured in the presence of Rucox (Fig. 5A). Consistent with its inability to prevent luciferase aggregation (Fig. 4A), Rucred had no significant effect on luciferase refolding (Fig. 5A). These results demonstrate that unfolded proteins that are bound by Ruc under oxidizing conditions can be refolded by the DnaKJE system.
After establishing the chaperone activity of Ruc in vitro, we sought to better understand the specific role of Ruc in M. tuberculosis physiology by identifying potential protein interaction partners in vivo. To capture such interactions, we produced Ruc with a hexahistidine-FLAG tandem affinity purification tag (RucTAP) in M. tuberculosis. When we performed a two-step purification of RucTAP from M. tuberculosis lysates under native conditions, we observed that a second protein copurified with RucTAP (Fig. 5B); mass spectrometry identified this protein as DnaK (see Materials and Methods). We validated the identity of DnaK in RucTAP purifications by immunoblotting with a monoclonal antibody to DnaK (Fig. S2A). Importantly, this result was specific to RucTAP, as DnaK did not copurify with another small TAP-tagged protein, PrcBTAP (Fig. S2A). This apparent interaction between Ruc and DnaK in M. tuberculosis lysates supports the hypothesis that Ruc is directly involved in maintaining protein folding by the DnaKJE system in vivo.
Notably, RucTAP interacted with DnaK under native purification conditions in which no oxidants were added. Given that Ruc chaperone function is activated under oxidizing conditions, we next sought to capture the interaction of Ruc with endogenous client proteins by purifying RucTAP from bacteria subjected to oxidative stress, a condition that could promote the association of RucTAP with unfolded substrates. However, when we purified RucTAP from M. tuberculosis cultures that were exposed to a sublethal concentration of H2O2 and CuCl2 at 45°C, we did not observe any additional proteins copurifying with RucTAP (Fig. S2B). We hypothesized that intact M. tuberculosis rapidly reverses oxidation such that interactions between Rucox and unfolded client proteins are too transient to capture. We instead treated lysates of RucTAP-producing M. tuberculosis with H2O2 and CuCl2, and found that oxidation resulted in the association of many M. tuberculosis proteins with RucTAP (Fig. 5C, lane 2). To determine the identity of these putative clients of Ruc, we performed proteomic mass spectrometry to identify the proteins that copurified with RucTAP under oxidizing, but not native, conditions (Table S2). Proteins that copurified with activated RucTAP were associated with a diverse range of functions, including nitrogen and carbon metabolism, electron transport, oxidative stress, and transcriptional regulation; thus, Ruc chaperone activity likely provides a general protective effect on the M. tuberculosis proteome during oxidation. While these results suggest that Ruc can interact with a wide variety of proteins, it remains to be determined if the same interactions take place within bacteria under any condition.
Ruc is not essential for M. tuberculosis resistance to several oxidative stresses in vitro.
During an infection, M. tuberculosis primarily resides within macrophages and neutrophils (44). These immune cells are capable of mounting an antimicrobial response that includes the generation of reactive oxygen species (ROS), reactive nitrogen intermediates (RNI), and hypochlorite. These molecules, all of which can react with cysteine thiols, can confer lethal stress upon infecting pathogens (reviewed in reference 45). Animals defective in the ability to produce ROS, RNI, and hypochlorite are more susceptible to bacterial and fungal pathogens (46–49), and human deficiency in ROS production is associated with susceptibility to mycobacterial infections (50).
Our data thus far led us to hypothesize that Ruc contributes to M. tuberculosis physiology by protecting bacteria from protein aggregation during oxidative stress. Therefore, we sought to test if a ruc mutant was more susceptible to a variety of oxidative stress conditions in vitro. We challenged M. tuberculosis strains incubated at 45°C with either peroxide, hypochlorite, plumbagin (which generates superoxide radicals in cells) (51), or acidified nitrite (which produces NO) (52) and qualitatively assessed the approximate lethal dose of each compound. The WT and ruc mutant strains were equally susceptible to killing under all stress conditions tested (Fig. S3A). We also measured the sensitivity of M. tuberculosis to peroxide stress in a quantitative assay and again observed that the ruc mutant was as sensitive to oxidation as the WT strain (Fig. S3B). Thus, in addition to our observation that the ruc mutant does not have a significant virulence defect in C57BL/6J mice, we were unable to conclusively determine if Ruc protects M. tuberculosis from the various oxidative stress conditions that might be encountered inside or outside a host. Given that M. tuberculosis has multiple mechanisms for maintaining bacterial redox balance, including thioredoxins, mycothiol, and catalase (reviewed in reference 53), it is possible that the contribution of Ruc to M. tuberculosis fitness only becomes apparent under conditions in which these antioxidant systems are not fully effective. Along these lines, the requirement for Hsp33 for E. coli resistance to oxidative stress was initially observed only after the thioredoxin system was genetically disrupted (17).
DISCUSSION
In this study, we identified Ruc as the founding member of a new family of bacterial redox-regulated chaperones. Prior to this work, Hsp33, RidA, and CnoX were the only other proteins described in bacteria whose chaperone activity is dependent on oxidation. Remarkably, however, Ruc shares no sequence similarity to these proteins aside from the presence of four zinc-coordinating cysteines, a feature of Hsp33. Reduced, inactive Hsp33 compactly folds into two globular domains; a combination of high temperature and oxidation causes partial unfolding of the protein, exposing a disordered region with a high affinity for substrates (41, 42). The Hsp33 zinc-binding motif, while essential for inducing conformational changes upon oxidation, does not directly participate in substrate binding (41). In contrast to Hsp33, Ruc likely has a single, small globular region and is predicted to be intrinsically disordered across more than half the length of the protein. We therefore expect that the mechanism of its activation is distinct from that of Hsp33. Our observation that Rucred has no chaperone activity suggests that the disordered domain of Rucred is kept in a partially occluded state, perhaps by interacting with other regions of the protein, and would therefore be unavailable for binding a client protein until oxidation takes place. Structural studies of Ruc, both alone and in complex with a substrate, will be necessary to determine the precise mechanism of its activation.
It is well established that Hsp33, CnoX, and sHsps deliver unfolded proteins to ATPase chaperones for refolding (5, 6, 22, 43). Here, we describe a similar function of Ruc in promoting protein folding by M. tuberculosis DnaKJE (Fig. 6). Importantly, despite strong evidence that proteins can be directly transferred from non-ATPase to ATPase chaperones, a direct interaction between a holdase and an Hsp70 chaperone has never been observed (15). Thus, our ability to capture the interaction of Ruc and DnaK, even in the absence of environmental stress, may present a new opportunity to understand mechanisms by which holdases transfer their substrates to DnaK.
While oxidized Ruc supports protein folding by DnaKJE, a chaperone system that is essential for M. tuberculosis viability (54), we found that Ruc is dispensable for M. tuberculosis survival under the in vitro and in vivo conditions tested in this study. However, ruc is conserved across pathogenic mycobacteria, including Mycobacterium leprae, a species whose genome has undergone extensive gene loss and is thought to contain only “core” mycobacterial genes (55). Thus, we propose that Ruc is required for M. tuberculosis survival under specific stress conditions that were not fully recapitulated in our experiments. Notably, a previous screen to identify genes required for M. tuberculosis virulence in mice during mixed infections found that bacteria with transposon insertions in ruc exhibited approximately 2-fold less growth in vivo than growth in vitro (56), possibly mirroring the subtle phenotype we observed in our mouse infections. In another study, mice of a different genetic background (BALB/c) that were infected with an M. tuberculosis strain containing a deletion and disruption mutation of Rv0990c (encoding Hsp22.5), the gene directly downstream of ruc, had a lower bacterial burden during the later stages of infection and increased time to death than mice infected with a WT strain; however, the phenotypes in this study could not be fully complemented (57). Conceivably, the Rv0990c mutation could have affected Ruc production, which might explain the incomplete complementation of the Rv0990c mutation to fully restore virulence. Furthermore, the phenotype of the Rv0990c mutant was observed at a later time point than those analyzed in this work.
The widespread conservation of Ruc homologs suggests that this protein protects bacteria against one or more common environmental stresses, as is the case for Hsp33. In a comparison of the phyletic distribution of Hsp33 and Ruc (Fig. S4), both proteins are present in certain bacterial lineages but strongly anticorrelated in others. For example, Hsp33 is widespread in Firmicutes, Cyanobacteria, Alphaproteobacteria, and Gammaproteobacteria (>80% of species), whereas Ruc is only rarely found in these organisms. In contrast, in lineages such as Planctomycetes, Chloroflexi, and Actinobacteria (including Mycobacteria), Hsp33 homologs are rare or absent, while Ruc homologs tend to be dominantly encoded by these genomes (Fig. S4). We therefore speculate that for these species, Ruc fulfills a similar role to that of Hsp33, preventing the irreversible aggregation of unfolded proteins during oxidative stress, a condition in which ATP depletion or direct thiol modification of DnaK may render DnaKJE-mediated refolding impossible (6, 20, 58). If this scenario were indeed supported by further studies, then Ruc and Hsp33, which appear to be structurally unrelated, may represent products of convergent evolution.
MATERIALS AND METHODS
Strains, plasmids, primers, and culture conditions.
See Table 1 for strains, plasmids, and primers used in this work. Reagents used for making all buffers and bacterial media were purchased from Thermo Fisher Scientific unless otherwise indicated. M. tuberculosis was grown in 7H9c (BD Difco Middlebrook 7H9 broth with 0.2% glycerol and supplemented with 0.5% bovine serum albumin [BSA], 0.2% dextrose, 0.085% sodium chloride, and 0.05% Tween 80). For the experiment in Fig. 1C, bacteria were grown in Proskauer-Beck minimal medium supplemented with asparagine and a similar result was observed in 7H9c. For solid media, M. tuberculosis was grown on 7H11 agar (BD Difco Middlebrook 7H11) containing 0.5% glycerol and supplemented with 10% final volume of BBL Middlebrook OADC enrichment. For selection of M. tuberculosis, the following antibiotics were used as needed: kanamycin 50 μg/ml and hygromycin 50 μg/ml. E. coli was cultured in BD Difco Luria-Bertani (LB) broth or on LB agar. Media were supplemented with the following antibiotics as needed: kanamycin, 100 μg/ml; hygromycin, 150 μg/ml; and ampicillin, 200 μg/ml.
Primers used for PCR amplification or sequencing were purchased from Life Technologies and are listed in Table 1. DNA was PCR amplified using either Phusion (New England Biolabs [NEB]), Pfu (Agilent), or Taq (Qiagen) according to the manufacturers’ instructions. PCR products were purified using the QIAquick gel extraction kit (Qiagen). Plasmids encoding His6-SUMO-Ruc, His6-SUMO-RucNterm, His6-SUMO-RucC8S,C11S, and His6-SUMO-RucC29S,C32S were made using splicing by overlap extension (SOE) PCR (59). Restriction enzymes and T4 DNA ligase were purchased from NEB. The following plasmids were made by PCR-amplifying genes from M. tuberculosis DNA using the indicated primers and cloning amplification products into their respective vectors: pET24b(+)-Rv0991c-his6 (NdeI-Rv0991c-F, HindIII-Rv0991c-R); pMV306kan-Rv0991c (HindIII-Rv0991c-F, XbaI-Rv0991c-R); pOLYG-Rv0991c-TAP (HindIII-Rv0991c-F, XbaI-Rv0991c-TAP-R); pAJD107-Rv0991c (NdeI-Rv0991c-F, BglII-Rv0991c-R); and pAJD107-Rv0991c-C8S,C11S (NdeI-Rv0991c-C8S,C11S-F, BglII-Rv0991c-R). pET24b(+)-Rv0991c and pET24b(+)-Rv0991c-C8S,C11S were made by subcloning the Rv0991c gene from pAJD107-Rv0991c and pAJD107-Rv0991c-C8S,C11S into pET24b(+), respectively. pET24b(+)-HisSUMO-ruc was made by first PCR amplifying HisSUMO from pEcTL02 using primers T7-F and SUMO-Ruc-soeR, second, amplifying ruc from M. tuberculosis DNA using SUMO-Ruc-soeF and Ruc-KpnI-R, and, finally, performing SOE PCR using these two amplification products along with primers T7-F and Ruc-Kpn-R. The SOE PCR product was then cloned into pET24b(+). pET24b(+)-HisSUMO-ruc-Nterm was made similarly except that the primer RucNterm-KpnI-R substituted for Ruc-KpnI. pET24b(+)-HisSUMO-ruc-C29S,C32S was made by SOE PCR using primers T7-F, T7-term, Rv0991c-C29SC32S-F, and Rv0991c-C29SC32S-R, with pET24b(+)-HisSUMO-ruc as the PCR template. pET24b(+)-HisSUMO-ruc-C8SC11S was made similarly to pET-24b(+)-HisSUMO-ruc except that the amplification product from primers SUMO-Ruc-soeF and Ruc-KpnI-R was made using pET24b(+)-Rv0991c-C8S,C11S as a template.
Calcium chloride-competent E. coli DH5α was transformed with ligations. All plasmids were purified from E. coli using the QIAprep spin miniprep kit. All plasmids made by PCR cloning were sequenced by Genewiz, Inc. to ensure the veracity of the cloned sequence. Plasmids were transformed into M. tuberculosis by electroporation as previously described (60). Single-colony transformants were isolated on 7H11 agar with antibiotic selection.
Protein purification, antibody production, and immunoblotting.
Ruc-His6 was produced in E. coli strain ER2566; His6-SUMO-Ruc, His6-SUMO-RucNterm, His6-SUMO-RucC8S,C11S, His6-SUMO-RucC29S,C32S, His6-SUMO-DnaK, His6-SUMO-DnaJ2, His6-SUMO-GrpE, and His6-Ulp1 were produced in E. coli strain BL21. Proteins were purified from E. coli by affinity chromatography using Ni-nitrilotriacetic acid (NTA) agarose (Qiagen) according to the manufacturer’s instructions (Ruc-His6 was purified under urea denaturing conditions). Production of His6-SUMO-DnaK, His6-SUMO-DnaJ2, and His6-SUMO-GrpE in E. coli was performed as previously described (12). To make rabbit polyclonal immune serum, approximately 200 μg Ruc-His6 was used to immunize rabbits (Covance, Denver, PA).
M. tuberculosis Ruc was prepared from E. coli using two methods that yielded approximately equal purity; both methods also resulted in identical Ruc chaperone activity upon oxidation of the protein. In the first method, untagged Ruc was purified from strain ER2566. A 500-ml culture was grown at 37°C with shaking to an optical density at 600 nm (OD600) of 0.5 and then cooled to room temperature. We added 1 mM isopropyl β-d-thiogalactopyranoside (IPTG), and the culture was grown further at 30°C with shaking for 5 h. Bacteria were collected by centrifugation, resuspended in 25 ml of 50 mM Tris, pH 8.0, and lysed by sonication. After removing insoluble material by centrifugation, ammonium sulfate was added to the lysate to 70% wt/vol, and the suspension was stirred for 30 min at 4°C to precipitate proteins. The precipitate was collected by centrifugation, resuspended in 3 ml of 50 mM Tris, pH 8.0, and dialyzed against 4 liters of the same buffer at 4°C overnight to remove residual ammonium sulfate and dissolve proteins. Ruc has a predicted isoelectric point of approximately 9 and was therefore one of the few positively charged proteins in the bacterial protein extract. Taking advantage of this fact, Ruc was purified to homogeneity by passing the protein extract over a Q-Sepharose anion exchange column (GE); Ruc immediately exited the column in flowthrough fractions. To ensure that the protein was fully reduced after purification, we treated Ruc with 5 mM dithiothreitol (DTT) for 30 min at 30°C. An Amicon centrifugal filter unit (Millipore) was used to thoroughly buffer exchange the protein into 50 mM HEPES, pH 7.5. The complete removal of DTT was confirmed by measuring the presence of DTT in the filter flowthrough using Ellman’s reagent (Thermo Scientific) according to the manufacturer’s instructions. The final protein preparation (Rucred) was stored in the same buffer at −20°C.
The second method of preparing Ruc from E. coli used a cleavable affinity tag and was also used to obtain RucNterm, RucC8S,C11S, and RucC29S,C32S. His6-SUMO-Ruc, His6-SUMO-RucNterm, His6-SUMO-RucC8S,C11S, and His6-SUMO-RucC29S,C32S were each purified from strain BL21(DE3) in the following manner. A 500-ml culture was grown at 37°C with shaking to an OD600 of 0.3 to 0.4, then transferred to a 25°C shaking incubator, and grown to an OD600 of 0.5. We added 1 mM IPTG, and the culture was further grown for 5 h. Purified protein was prepared from bacteria using Ni-NTA resin and then exchanged into a SUMO cleavage buffer of 50 mM Tris, 150 mM NaCl, 2 mM DTT, pH 8.0. A 1:100 volume of purified His6-Ulp1 (SUMO protease) was added, and the reaction mixture was incubated for 30 min at 30°C. His6-Ulp1 and His6-SUMO were then removed by incubating the mixture with Ni-NTA resin and saving the supernatant fraction; clearance of tagged protein was performed twice to yield pure, native Ruc and truncation or substitution variants. Proteins were buffer exchanged into Tris-buffered saline (TBS) buffer (50 mM Tris, 150 mM NaCl, pH 8.0) using centrifugal filters, and the absence of residual DTT was confirmed using Ellman’s reagent. The final protein preparations (Rucred, RucNterm-red, RucC8S,C11S-red, and RucC29S,C32S-red) were stored in TBS at −20°C.
M. tuberculosis DnaK, DnaJ2, and GrpE were prepared by removing the affinity tags from His6-SUMO-DnaK, His6-SUMO-DnaJ2, and His6-SUMO-GrpE in the same manner as described for His6-SUMO-Ruc except that the native proteins were buffer exchanged into 50 mM Tris, 150 mM KCl, 20 mM MgCl2, and 2 mM DTT, pH 7.5, before storage at −20°C.
Separation of proteins in in vitro assays and in M. tuberculosis lysates was performed using 15% sodium dodecyl sulfate-polyacrylamide (SDS-PAGE) gels, with the following exceptions. For Fig. 1B and C, AnykD Mini-Protean TGX precast protein gels (Bio-Rad) were used. Bio-Safe Coomassie stain (Bio-Rad) was used to stain gels. For preparing samples for SDS-PAGE gels in Fig. 3A and Fig. 4B, purified proteins were mixed with 4× nonreducing SDS buffer (250 mM Tris, pH 6.8, 2% SDS, 40% glycerol, and 1% bromophenol blue) to a 1× final concentration, and samples were boiled for 5 min. For Fig. 3A, lane 3, DTT was added to the sample to a 2-mM final concentration prior to boiling. For immunoblots, proteins were transferred from protein gels to nitrocellulose membranes (GE Amersham) and analyzed by immunoblotting as indicated. Due to Ruc’s high isoelectric point, Ruc was transferred to membranes using 100 mM N-cyclohexyl-3-aminopropanesulfonic acid (CAPS) buffer in 10% methanol. In Fig. 1B and C, Ruc and PrcB immunoblots were from the same membrane. For detecting M. tuberculosis DnaK, we used a monoclonal antibody from BEI Resources (catalog no. NR-13609) at a concentration of 1:1,000 in 3% BSA in 25 mM Tris-Cl/125 mM NaCl/0.05% Tween 20 buffer (TBST). Polyclonal antibodies against PrcB (25) and Ruc were used similarly. Secondary antibodies horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG F(ab')2 and HRP-conjugated anti-mouse IgG (H+L) were purchased from Thermo Fisher Scientific. All antibodies were made in TBST with 3% BSA. Immunoblots were developed using SuperSignal West Pico Plus chemiluminescent substrate (Thermo Fisher Scientific) and imaged using a Bio-Rad ChemiDoc system.
Preparation of M. tuberculosis extracts for immunoblotting.
M. tuberculosis cultures were grown to an OD580 of 0.3. Equal amounts of bacteria were harvested by centrifugation, resuspended in TBS, and transferred to a tube containing 250 μl of 0.1 mm zirconia beads (BioSpec Products). Bacteria were lysed using a mechanical bead beater (BioSpec Products). Whole lysates were mixed with 4× reducing SDS sample buffer (250 mM Tris, pH 6.8, 2% SDS, 20% 2-mercaptoethanol, 40% glycerol, and 1% bromophenol blue) to a 1× final concentration, and samples were boiled for 5 min. For preparing lysates from M. tuberculosis grown in 7H9, which contains BSA, an additional wash step with phosphate-buffered saline with Tween 20 (PBS-T) was done prior to resuspension of bacteria in lysis buffer.
Mouse infections.
Six- to eight-week-old female C57BL6/J mice (Jackson Laboratories) were each infected with ∼200 to 400 M. tuberculosis bacilli by the aerosol infection route. The bacterial burden in organs was determined as previously described (61). Briefly, at the time points indicated in the text, lung pairs and spleens were harvested from three to five mice for each experiment and were each homogenized and plated on 7H11 agar to determine CFU per organ. All procedures were performed with the approval of the New York University Institutional Animal Care and Use Committee.
Preparation of Rucox and RucNterm-ox.
We diluted 8.8 M H2O2 stock solution, stored at −20°C, to 200 mM in deionized water just prior to the oxidation reaction. We incubated 100 μM Rucred or RucNterm-red at 37°C for 3 min, after which 50 μM copper chloride was added, followed by 2 mM H2O2. The reaction mixture was incubated for 10 min; H2O2 and copper chloride were removed using a Zeba Spin 7K MWCO desalting centrifuge column (Fisher Scientific) preequilibrated with the original Rucred storage buffer according to the manufacturer’s instructions. Treatment of Ruc with 2 mM diethylamine NONOate (DEANO, a nitric oxide donor) (Sigma-Aldrich) or NaOCl (Fig. S1B) was performed identically except that Ruc was treated for 20 min (NaOCl) or 2 h (DEANO) as described for Hsp33 (62).
Spectrophotometric detection of zinc in Ruc preparations.
Quantification of the zinc coordinated by Ruc cysteines was performed using 4-(2-pyridylazo)resorcinol (PAR) using a previously established method (34, 63) except that zinc-cysteine complexes were disrupted using N-ethylmaleimide (NEM) (Pierce) according to the manufacturer’s instructions. We mixed 25 μM Ruc with 100 μM PAR either in the absence or presence of 2 mM NEM. Reaction mixtures were incubated at room temperature for 1 h. Zn(PAR)2 complexes were detected by A500 using a NanoDrop spectrophotometer. To obtain a precise concentration of zinc in protein preparations, serial dilutions of zinc sulfate prepared in matched buffers (with or without NEM) were used to prepare standard curves. Three technical replicates were performed for each condition.
Metal analysis of Ruc preparations using ICP-MS.
Elemental quantification of purified Ruc with and without NEM and a buffer control was performed using an Agilent 7700 inductively coupled plasma mass spectrometer (Agilent, Santa Clara, CA) attached to a Teledyne Cetac Technologies ASX-560 autosampler (Teledyne Cetac Technologies, Omaha, NE). The following settings were fixed for the analysis: cell entrance, −40 V; cell exit, −60 V; plate bias, −60 V; OctP bias, −18 V; and collision cell helium flow, 4.5 ml/min. Optimal voltages for extract 2, omega bias, omega lens, OctP RF, and deflect were determined empirically before each sample set was analyzed. Element calibration curves were generated using Aristar ICP standard mix (VWR, Radnor, PA). Samples were introduced by peristaltic pump with 0.5-mm internal diameter tubing through a MicroMist borosilicate glass nebulizer (Agilent). Samples were initially taken at 0.5 revolutions per second (rps) for 30 s followed by 30 s at 0.1 rps to stabilize the signal. Samples were analyzed in spectrum mode at 0.1 rps, collecting three points across each peak and performing three replicates of 100 sweeps for each element analyzed. Sampling probe and tubing were rinsed for 20 s at 0.5 rps with 2% nitric acid between every sample. Data were acquired and analyzed using the Agilent Mass Hunter workstation software version A.01.02.
CD spectrophotometry.
CD measurements were performed using a Jasco J-1500 CD spectrophotometer as per the manufacturer's instructions. To prepare samples, Ruc was buffer exchanged into 20 mM KH2PO4, pH 7.5, diluted to 20 μM, and transferred to a quartz cuvette. The spectrophotometer parameters were set as follows: CD scale, 200 millidegrees (mdeg)/1.0 delta optical density; integration time, 1 s; and bandwidth, 1 nm. The voltage was monitored simultaneously and remained below 700 V.
Luciferase aggregation and refolding assays.
The chaperone activity of Ruc was measured by testing its ability to limit the aggregation of heat-denatured luciferase, a previously established method (16, 39). For experiments in Fig. 4A, C, and E, aggregation was determined by measuring absorbance at 350 nm (A350) (64, 65). Firefly luciferase (Promega) was diluted to 2 μM in TBS and mixed in a microcentrifuge tube with concentrations of Ruc indicated in the text and figures, or TBS alone, to a final volume of 20 μl. The tube was then incubated in a 45°C heat block. Immediately before incubation and at the indicated times, a 2-μl volume was removed, and A350 was measured using a NanoDrop spectrophotometer. Aggregation assays were performed using three technical replicates per condition. For the experiment in Fig. S1A, luciferase aggregation was measured using light scattering as previously described (16).
Refolding of heat-denatured luciferase by M. tuberculosis DnaKJE was performed using a protocol adapted from reference 12. M. tuberculosis encodes two DnaJ homologs, DnaJ1 and DnaJ2, which both promote DnaK-mediated protein folding in vitro (12); DnaJ2 was used in this study because we found that DnaJ1 exhibited poor solubility when purified from E. coli. For the denaturation step, luciferase was diluted to 0.1 μM in TBS, either alone or mixed with 4 μM Rucred or Rucox, in glass vials. Denaturation was performed by placing vials in a 45°C water bath for 20 min. For the refolding step, we used glass-coated 96-well plates in which 5 μl of denaturation reaction was mixed with 15 μl of refolding reaction buffer (50 mM Tris pH 7.5, 150 mM KCl, 20 mM MgCl2, 2 mM DTT, 1 mg/ml BSA [Sigma-Aldrich], and 2 mM Mg2+-ATP) or refolding reaction buffer containing 4 μM DnaK, 2 μM DnaJ2, and 2 μM GrpE. Plates were incubated at 25°C. Luciferase activity was measured immediately upon initiating the refolding step (0 min) and at all other time points indicated in Fig. 5A by transferring 2 μl of each reaction into a white opaque 96-well plate and adding 100 μl of luciferase assay mix (100 mM KH2PO4, pH 7.5, 25 mM glycyl glycine, 0.2 mM EDTA, 2 mM Mg2+-ATP, 0.5 mg/ml BSA, and 70 μM luciferin). Luminescence was measured using a plate reader (PerkinElmer EnVision). For calculating the percentage of native luciferase activity for all reactions at each time point, a control reaction was included in which 0.1 μM luciferase was diluted into TBS in a glass vial but kept at 4°C, rather than heated, during the denaturation step. This control reaction was mixed with refolding reaction buffer as described above, and luminescence was measured at each time point in Fig. 5A to determine 100% native luciferase activity.
Tandem affinity purification of M. tuberculosis proteins.
Purifications of TAP-tagged proteins from M. tuberculosis were performed under low-salt conditions as described (66). The following changes were made to the protocol: 100 μl of packed Ni-NTA beads and 100 μl of M2 anti-FLAG affinity gel were used; 100 μl of 100 μM 3 × FLAG peptide was used for the final elution. For capturing RucTAP interactions with other M. tuberculosis proteins, M. tuberculosis lysates were incubated at 45°C for 10 min either in the absence (Fig. 5C, lane 1) or presence (Fig. 5C, lane 2) of 2 mM H2O2 and 50 μM CuCl2; purifications were subsequently performed as described above. Samples were boiled in 4× reducing SDS sample buffer prior to running SDS-PAGE gels.
Protein mass spectrometry.
To identify the ∼70-kDa protein pulled down by RucTAP (Fig. 5B), the band was excised from SDS-PAGE gel and processed as previously described (67). To determine the identity of proteins enriched in RucTAP purifications under oxidizing conditions (Fig. 5C; Table S2), RucTAP purifications under native or oxidizing conditions were performed in three biological replicates. Affinity-purified samples were reduced, alkylated, digested with trypsin, and desalted as previously described (25, 67). The peptide eluates in all cases were concentrated in the SpeedVac and stored at −80°C. Aliquots of each sample were loaded onto a trap column (Acclaim PepMap 100 precolumn, 75 μm by 2 cm, C18, 3 μm, 100 Å; Thermo Scientific) connected to an analytical column (Easy-Spray column, 50 m by 75 μm ID, PepMap RSLC C18, 2 μm, 100 Å, Thermo Scientific) using the autosampler of an Easy-nLC 1000 (Thermo Scientific) with solvent A consisting of 2% acetonitrile in 0.5% acetic acid and solvent B consisting of 80% acetonitrile in 0.5% acetic acid. The peptide mixture was gradient eluted into the Orbitrap Q Exactive HF-X mass spectrometer (Thermo Scientific) using the following gradient: 5% to 35% solvent B in 120 min and 35% to 45% solvent B in 10 min followed by 45% to 100% solvent B in 20 min. The full scan was acquired with a resolution of 45,000 (at m/z 200), a target value of 3E6, and a maximum ion time of 45 ms. Following each full MS scan, 20 data-dependent tandem mass spectrometry (MS/MS) spectra were acquired. The MS/MS spectra were collected with a resolution of 15,000 (at m/z 200), an automatic gain control (AGC) target of 1E5, maximum ion time of 120 ms, one microscan, 2 m/z isolation window, fixed first mass of 150 m/z, dynamic exclusion of 30 s, and normalized collision energy (NCE) of 27. All acquired MS2 spectra were searched against a UniProt M. tuberculosis H37Rv database, including common contaminant proteins using Sequest HT within Proteome Discoverer 1.4 (Thermo Fisher Scientific). The search parameters were as follows: precursor mass tolerance, ±10 ppm; fragment mass tolerance, ±0.02 Da; digestion parameters, trypsin allowing two missed cleavages; fixed modification of carbamidomethyl on cysteine; variable modification of oxidation on methionine; and variable modification of deamidation on glutamine and asparagine and a 1% peptide and protein false discovery rate (FDR) searched against a decoy database. The results were filtered to only include proteins identified by at least two unique peptides. Fold change analysis was performed for the RucTAP purifications using the ratios of peptide spectral matches (PSMs) in oxidized samples to the PSMs in the native affinity-purified samples using the SAINT algorithm (68). SAINT scores were used to calculate the FDR; proteins whose SAINT score yielded an FDR of 5% or lower were considered statistically significant and are highlighted in Table S2.
Measurement of M. tuberculosis susceptibility to oxidants.
M. tuberculosis was grown in 7H9c to an OD580 of 0.5 at 37°C, centrifuged and resuspended in fresh 7H9c, and spun at 500 × g to remove clumps of bacteria. Supernatants were then diluted to an OD580 of 0.025, transferred to 96-well plates, and incubated at 45°C for 4 h to induce Ruc production. Afterward, M. tuberculosis strains were subjected to oxidizing reagents and inoculated onto 7H11 agar as described in the legend for Fig. S3.
Computational analyses.
Iterative sequence profile searches were performed to recover Ruc sequence homologs using the PSI-BLAST program (69). Searches were either run against the nonredundant (nr) protein database of the National Center for Biotechnology Information (NCBI) or a custom database of 7,423 complete prokaryotic genomes extracted from the NCBI RefSeq database (70). The latter was used for phyletic profile analyses (Table 2). Contextual information from prokaryotic gene neighborhoods was retrieved using a Perl script that extracts the upstream and downstream genes of a query gene from a GenBank genome file. This was followed by clustering of proteins using the BLASTCLUST program (ftp://ftp.ncbi.nih.gov/blast/documents/blastclust.html) to identify conserved gene neighborhoods. Analysis and visualization of phyletic patterns were performed using the R language.
ACKNOWLEDGMENTS
We thank A. Jordan for proofreading a draft of the manuscript. We thank C. Nathan and K. Burns-Huang for providing strains and technical advice.
This work was supported by NIH grants AI088075 and AI144851 awarded to K.H.D. and GM122506 to U.J. S.H.B. was supported by NIH grant T32 AT007180. S.H.B. also received support from the Jan T. Vilcek Endowed Fellowship Fund. E.P.S. received support from AI150701 and AI069233. K.U. and U.J. thank the DFG Priority Program SPP 1710 (Schw823/3-2). L.M.I. and L.A. are supported by the intramural funds of the National Library of Medicine, NIH. The mass spectrometry experiments were in part supported by the NYU Grossman School of Medicine.
S.H.B., K.U., A.D., B.U., W.B., E.P.S., L.M.I., L.A., U.J., and K.H.D. designed research; S.H.B., K.U., A.D., W.B., L.M.I., and L.A. performed research; and S.H.B., K.H.D., and L.A. wrote the manuscript.
Footnotes
Citation Becker SH, Ulrich K, Dhabaria A, Ueberheide B, Beavers W, Skaar EP, Iyer LM, Aravind L, Jakob U, Darwin KH. 2020. Mycobacterium tuberculosis Rv0991c is a redox-regulated molecular chaperone. mBio 11:e01545-20. https://doi.org/10.1128/mBio.01545-20.
REFERENCES
- 1.Rosenzweig R, Nillegoda NB, Mayer MP, Bukau B. 2019. The Hsp70 chaperone network. Nat Rev Mol Cell Biol 20:665–680. doi: 10.1038/s41580-019-0133-3. [DOI] [PubMed] [Google Scholar]
- 2.Laufen T, Mayer MP, Beisel C, Klostermeier D, Mogk A, Reinstein J, Bukau B. 1999. Mechanism of regulation of Hsp70 chaperones by DnaJ cochaperones. Proc Natl Acad Sci U S A 96:5452–5457. doi: 10.1073/pnas.96.10.5452. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Liberek K, Skowyra D, Zylicz M, Johnson C, Georgopoulos C. 1991. The Escherichia coli DnaK chaperone, the 70-kDa heat shock protein eukaryotic equivalent, changes conformation upon ATP hydrolysis, thus triggering its dissociation from a bound target protein. J Biol Chem 266:14491–14496. [PubMed] [Google Scholar]
- 4.Harrison CJ, Hayer-Hartl M, Di Liberto M, Hartl F, Kuriyan J. 1997. Crystal structure of the nucleotide exchange factor GrpE bound to the ATPase domain of the molecular chaperone DnaK. Science 276:431–435. doi: 10.1126/science.276.5311.431. [DOI] [PubMed] [Google Scholar]
- 5.Veinger L, Diamant S, Buchner J, Goloubinoff P. 1998. The small heat-shock protein IbpB from Escherichia coli stabilizes stress-denatured proteins for subsequent refolding by a multichaperone network. J Biol Chem 273:11032–11037. doi: 10.1074/jbc.273.18.11032. [DOI] [PubMed] [Google Scholar]
- 6.Hoffmann JH, Linke K, Graf PCF, Lilie H, Jakob U. 2004. Identification of a redox-regulated chaperone network. EMBO J 23:160–168. doi: 10.1038/sj.emboj.7600016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Fernández-Fernández MR, Gragera M, Ochoa-Ibarrola L, Quintana-Gallardo L, Valpuesta JM. 2017. Hsp70 – a master regulator in protein degradation. FEBS Lett 591:2648–2660. doi: 10.1002/1873-3468.12751. [DOI] [PubMed] [Google Scholar]
- 8.Rodriguez F, Arsene-Ploetze F, Rist W, Rudiger S, Schneider-Mergener J, Mayer MP, Bukau B. 2008. Molecular basis for regulation of the heat shock transcription factor sigma32 by the DnaK and DnaJ chaperones. Mol Cell 32:347–358. doi: 10.1016/j.molcel.2008.09.016. [DOI] [PubMed] [Google Scholar]
- 9.Zolkiewski M. 1999. ClpB cooperates with DnaK, DnaJ, and GrpE in suppressing protein aggregation: a novel multi-chaperone system from Escherichia coli. J Biol Chem 274:28083–28086. doi: 10.1074/jbc.274.40.28083. [DOI] [PubMed] [Google Scholar]
- 10.Goloubinoff P, Mogk A, Zvi AP, Tomoyasu T, Bukau B. 1999. Sequential mechanism of solubilization and refolding of stable protein aggregates by a bichaperone network. Proc Natl Acad Sci U S A 96:13732–13737. doi: 10.1073/pnas.96.24.13732. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Weibezahn J, Tessarz P, Schlieker C, Zahn R, Maglica Z, Lee S, Zentgraf H, Weber-Ban EU, Dougan DA, Tsai FTF, Mogk A, Bukau B. 2004. Thermotolerance requires refolding of aggregated proteins by substrate translocation through the central pore of ClpB. Cell 119:653–665. doi: 10.1016/j.cell.2004.11.027. [DOI] [PubMed] [Google Scholar]
- 12.Lupoli TJ, Fay A, Adura C, Glickman MS, Nathan CF. 2016. Reconstitution of a Mycobacterium tuberculosis proteostasis network highlights essential cofactor interactions with chaperone DnaK. Proc Natl Acad Sci U S A 113:E7947–E7956. doi: 10.1073/pnas.1617644113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Haslbeck M, Weinkauf S, Buchner J. 2019. Small heat shock proteins: simplicity meets complexity. J Biol Chem 294:2121–2132. doi: 10.1074/jbc.REV118.002809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Ehrnsperger M, Gräber S, Gaestel M, Buchner J. 1997. Binding of non-native protein to Hsp25 during heat shock creates a reservoir of folding intermediates for reactivation. EMBO J 16:221–229. doi: 10.1093/emboj/16.2.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Żwirowski S, Kłosowska A, Obuchowski I, Nillegoda NB, Piróg A, Ziętkiewicz S, Bukau B, Mogk A, Liberek K. 2017. Hsp70 displaces small heat shock proteins from aggregates to initiate protein refolding. EMBO J 36:783–796. doi: 10.15252/embj.201593378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Jakob U, Muse W, Eser M, Bardwell JCA. 1999. Chaperone activity with a redox switch. Cell 96:341–352. doi: 10.1016/S0092-8674(00)80547-4. [DOI] [PubMed] [Google Scholar]
- 17.Graf PCF, Martinez-Yamout M, VanHaerents S, Lilie H, Dyson HJ, Jakob U. 2004. Activation of the redox-regulated chaperone Hsp33 by domain unfolding. J Biol Chem 279:20529–20538. doi: 10.1074/jbc.M401764200. [DOI] [PubMed] [Google Scholar]
- 18.Voth W, Schick M, Gates S, Li S, Vilardi F, Gostimskaya I, Southworth DR, Schwappach B, Jakob U. 2014. The protein targeting factor Get3 functions as ATP-independent chaperone under oxidative stress conditions. Mol Cell 56:116–127. doi: 10.1016/j.molcel.2014.08.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Graumann J, Lilie H, Tang X, Tucker KA, Hoffmann JH, Vijayalakshmi J, Saper M, Bardwell JCA, Jakob U. 2001. Activation of the redox-regulated molecular chaperone Hsp33—a two-step mechanism. Structure 9:377–387. doi: 10.1016/S0969-2126(01)00599-8. [DOI] [PubMed] [Google Scholar]
- 20.Winter J, Linke K, Jatzek A, Jakob U. 2005. Severe oxidative stress causes inactivation of DnaK and activation of the redox-regulated chaperone Hsp33. Mol Cell 17:381–392. doi: 10.1016/j.molcel.2004.12.027. [DOI] [PubMed] [Google Scholar]
- 21.Müller A, Langklotz S, Lupilova N, Kuhlmann K, Bandow JE, Leichert LIO. 2014. Activation of RidA chaperone function by N-chlorination. Nat Commun 5:5804. doi: 10.1038/ncomms6804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Goemans CV, Vertommen D, Agrebi R, Collet JF. 2018. CnoX Is a chaperedoxin: a holdase that protects its substrates from irreversible oxidation. Mol Cell 70:614–627.e7. doi: 10.1016/j.molcel.2018.04.002. [DOI] [PubMed] [Google Scholar]
- 23.Voth W, Jakob U. 2017. Stress-activated chaperones: a first line of defense. Trends Biochem Sci 42:899–913. doi: 10.1016/j.tibs.2017.08.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.World Health Organization. Global tuberculosis report 2019. World Health Organization, Geneva, Switzerland. [Google Scholar]
- 25.Becker SH, Jastrab JB, Dhabaria A, Chaton CT, Rush JS, Korotkov KV, Ueberheide B, Darwin KH. 2019. The Mycobacterium tuberculosis Pup-proteasome system regulates nitrate metabolism through an essential protein quality control pathway. Proc Natl Acad Sci U S A 116:3202–3210. doi: 10.1073/pnas.1819468116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Stewart GR, Wernisch L, Stabler R, Mangan JA, Hinds J, Laing KG, Young DB, Butcher PD. 2002. Dissection of the heat-shock response in Mycobacterium tuberculosis using mutants and microarrays. Microbiology 148:3129–3138. doi: 10.1099/00221287-148-10-3129. [DOI] [PubMed] [Google Scholar]
- 27.Sharp JD, Singh AK, Park ST, Lyubetskaya A, Peterson MW, Gomes AL, Potluri LP, Raman S, Galagan JE, Husson RN. 2016. Comprehensive definition of the SigH regulon of Mycobacterium tuberculosis reveals transcriptional control of diverse stress responses. PLoS One 11:e0152145. doi: 10.1371/journal.pone.0152145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Vaubourgeix J, Lin G, Dhar N, Chenouard N, Jiang X, Botella H, Lupoli T, Mariani O, Yang G, Ouerfelli O, Unser M, Schnappinger D, McKinney J, Nathan C. 2015. Stressed mycobacteria use the chaperone ClpB to sequester irreversibly oxidized proteins asymmetrically within and between cells. Cell Host Microbe 17:178–190. doi: 10.1016/j.chom.2014.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Stewart GR, Newton SM, Wilkinson KA, Humphreys IR, Murphy HN, Robertson BD, Wilkinson RJ, Young DB. 2005. The stress-responsive chaperone alpha-crystallin 2 is required for pathogenesis of Mycobacterium tuberculosis. Mol Microbiol 55:1127–1137. doi: 10.1111/j.1365-2958.2004.04450.x. [DOI] [PubMed] [Google Scholar]
- 30.Stewart GR, Snewin VA, Walzl G, Hussell T, Tormay P, O'Gaora P, Goyal M, Betts J, Brown IN, Young DB. 2001. Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection. Nat Med 7:732–737. doi: 10.1038/89113. [DOI] [PubMed] [Google Scholar]
- 31.Kapopoulou A, Lew JM, Cole ST. 2011. The MycoBrowser portal: a comprehensive and manually annotated resource for mycobacterial genomes. Tuberculosis (Edinb) 91:8–13. doi: 10.1016/j.tube.2010.09.006. [DOI] [PubMed] [Google Scholar]
- 32.Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJE. 2015. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10:845–858. doi: 10.1038/nprot.2015.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Krishna SS, Majumdar I, Grishin NV. 2003. Structural classification of zinc fingers: survey and summary. Nucleic Acids Res 31:532–550. doi: 10.1093/nar/gkg161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Jakob U, Eser M, Bardwell JCA. 2000. Redox switch of Hsp33 has a novel zinc-binding motif. J Biol Chem 275:38302–38310. doi: 10.1074/jbc.M005957200. [DOI] [PubMed] [Google Scholar]
- 35.Park OK, Bauerle R. 1999. Metal-catalyzed oxidation of phenylalanine-sensitive 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase from Escherichia coli: inactivation and destabilization by oxidation of active-site cysteines. J Bacteriol 181:1636–1642. doi: 10.1128/JB.181.5.1636-1642.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Pollard FH, Hanson P, Geary WJ. 1959. 4–(2-Pyridylazo)-resorcinol as a possible analytical reagent for the colorimetric estimation of cobalt, lead, and uranium. Anal Chim Acta 20:26–31. doi: 10.1016/0003-2670(59)80004-0. [DOI] [Google Scholar]
- 37.Kelly SM, Jess TJ, Price NC. 2005. How to study proteins by circular dichroism. Biochim Biophys Acta 1751:119–139. doi: 10.1016/j.bbapap.2005.06.005. [DOI] [PubMed] [Google Scholar]
- 38.Greenfield NJ. 2006. Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 1:2876–2890. doi: 10.1038/nprot.2006.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Oh HJ, Chen X, Subjeck JR. 1997. hsp110 protects heat-denatured proteins and confers cellular thermoresistance. J Biol Chem 272:31636–31640. doi: 10.1074/jbc.272.50.31636. [DOI] [PubMed] [Google Scholar]
- 40.Buchner J, Grallert H, Jakob U. 1998. Analysis of chaperone function using citrate synthase as nonnative substrate protein. Methods Enzymol 290:323–338. doi: 10.1016/s0076-6879(98)90029-5. [DOI] [PubMed] [Google Scholar]
- 41.Groitl B, Horowitz S, Makepeace KAT, Petrotchenko EV, Borchers CH, Reichmann D, Bardwell JCA, Jakob U. 2016. Protein unfolding as a switch from self-recognition to high-affinity client binding. Nat Commun 7:10357. doi: 10.1038/ncomms10357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Reichmann D, Xu Y, Cremers CM, Ilbert M, Mittelman R, Fitzgerald MC, Jakob U. 2012. Order out of disorder: working cycle of an intrinsically unfolded chaperone. Cell 148:947–957. doi: 10.1016/j.cell.2012.01.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Mogk A, Deuerling E, Vorderwülbecke S, Vierling E, Bukau B. 2003. Small heat shock proteins, ClpB and the DnaK system form a functional triade in reversing protein aggregation. Mol Microbiol 50:585–595. doi: 10.1046/j.1365-2958.2003.03710.x. [DOI] [PubMed] [Google Scholar]
- 44.Cohen SB, Gern BH, Delahaye JL, Adams KN, Plumlee CR, Winkler JK, Sherman DR, Gerner MY, Urdahl KB. 2018. Alveolar macrophages provide an early mycobacterium tuberculosis niche and initiate dissemination. Cell Host Microbe 24:439–446.e4. doi: 10.1016/j.chom.2018.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Nathan C, Shiloh MU. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A 97:8841–8848. doi: 10.1073/pnas.97.16.8841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Jackson SH, Gallin JI, Holland SM. 1995. The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med 182:751–758. doi: 10.1084/jem.182.3.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Pollock JD, Williams DA, Gifford MAC, Li LL, Du X, Fisherman J, Orkin SH, Doerschuk CM, Dinauer MC. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 9:202–209. doi: 10.1038/ng0295-202. [DOI] [PubMed] [Google Scholar]
- 48.MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A 94:5243–5248. doi: 10.1073/pnas.94.10.5243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Aratani Y, Koyama H, Nyui S-I, Suzuki K, Kura F, Maeda N. 1999. Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 67:1828–1836. doi: 10.1128/IAI.67.4.1828-1836.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Deffert C, Cachat J, Krause K-H. 2014. Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections. Cell Microbiol 16:1168–1178. doi: 10.1111/cmi.12322. [DOI] [PubMed] [Google Scholar]
- 51.Shimada H, Yamaoka Y, Morita R, Mizuno T, Gotoh K, Higuchi T, Shiraishi T, Imamura Y. 2012. Possible mechanism of superoxide formation through redox cycling of plumbagin in pig heart. Toxicol in Vitro 26:252–257. doi: 10.1016/j.tiv.2011.12.007. [DOI] [PubMed] [Google Scholar]
- 52.Stuehr DJ, Nathan CF. 1989. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169:1543–1555. doi: 10.1084/jem.169.5.1543. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Lu J, Holmgren A. 2014. The thioredoxin antioxidant system. Free Radic Biol Med 66:75–87. doi: 10.1016/j.freeradbiomed.2013.07.036. [DOI] [PubMed] [Google Scholar]
- 54.Fay A, Glickman MS. 2014. An essential nonredundant role for mycobacterial DnaK in native protein folding. PLoS Genet 10:e1004516. doi: 10.1371/journal.pgen.1004516. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, Wheeler PR, Honoré N, Garnier T, Churcher C, Harris D, Mungall K, Basham D, Brown D, Chillingworth T, Connor R, Davies RM, Devlin K, Duthoy S, Feltwell T, Fraser A, Hamlin N, Holroyd S, Hornsby T, Jagels K, Lacroix C, Maclean J, Moule S, Murphy L, Oliver K, Quail MA, Rajandream MA, Rutherford KM, Rutter S, Seeger K, Simon S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Taylor K, Whitehead S, Woodward JR, Barrell BG. 2001. Massive gene decay in the leprosy bacillus. Nature 409:1007–1011. doi: 10.1038/35059006. [DOI] [PubMed] [Google Scholar]
- 56.Sassetti CM, Rubin EJ. 2003. Genetic requirements for mycobacterial survival during infection. Proc Natl Acad Sci U S A 100:12989–12994. doi: 10.1073/pnas.2134250100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Abomoelak B, Marcus SA, Ward SK, Karakousis PC, Steinberg H, Talaat AM. 2011. Characterization of a novel heat shock protein (Hsp22.5) involved in the pathogenesis of Mycobacterium tuberculosis. J Bacteriol 193:3497–3505. doi: 10.1128/JB.01536-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Zhang H, Yang J, Wu S, Gong W, Chen C, Perrett S. 2016. Glutathionylation of the bacterial Hsp70 chaperone DnaK provides a link between oxidative stress and the heat shock response. J Biol Chem 291:6967–6981. doi: 10.1074/jbc.M115.673608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51–59. doi: 10.1016/0378-1119(89)90358-2. [DOI] [PubMed] [Google Scholar]
- 60.Hatfull GF, Jacobs WR. 2000. Molecular genetics of mycobacteria. ASM Press, Washington, DC. [Google Scholar]
- 61.Samanovic MI, Tu S, Novak O, Iyer LM, McAllister FE, Aravind L, Gygi SP, Hubbard SR, Strnad M, Darwin KH. 2015. Proteasomal control of cytokinin synthesis protects Mycobacterium tuberculosis against nitric oxide. Mol Cell 57:984–994. doi: 10.1016/j.molcel.2015.01.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Winter J, Ilbert M, Graf PCF, Ozcelik D, Jakob U. 2008. Bleach activates a redox-regulated chaperone by oxidative protein unfolding. Cell 135:691–701. doi: 10.1016/j.cell.2008.09.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Hunt JB, Neece SH, Ginsburg A. 1985. The use of 4-(2-pyridylazo)resorcinol in studies of zinc release from Escherichia coli aspartate transcarbamoylase. Anal Biochem 146:150–157. doi: 10.1016/0003-2697(85)90409-9. [DOI] [PubMed] [Google Scholar]
- 64.Kurganov BI. 2002. Kinetics of protein aggregation. Quantitative estimation of the chaperone-like activity in test-systems based on suppression of protein aggregation. Biochemistry (Mosc) 67:409–422. doi: 10.1023/a:1015277805345. [DOI] [PubMed] [Google Scholar]
- 65.Pellaud J, Schote U, Arvinte T, Seelig J. 1999. Conformation and self-association of human recombinant transforming growth factor-β3 in aqueous solutions. J Biol Chem 274:7699–7704. doi: 10.1074/jbc.274.12.7699. [DOI] [PubMed] [Google Scholar]
- 66.Jastrab JB, Wang T, Murphy JP, Bai L, Hu K, Merkx R, Huang J, Chatterjee C, Ovaa H, Gygi SP, Li H, Darwin KH. 2015. An adenosine triphosphate-independent proteasome activator contributes to the virulence of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 112:E1763–E1772. doi: 10.1073/pnas.1423319112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Lignitto L, LeBoeuf SE, Homer H, Jiang S, Askenazi M, Karakousi TR, Pass HI, Bhutkar AJ, Tsirigos A, Ueberheide B, Sayin VI, Papagiannakopoulos T, Pagano M. 2019. Nrf2 activation promotes lung cancer metastasis by inhibiting the degradation of Bach1. Cell 178:316–329.e18. doi: 10.1016/j.cell.2019.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Choi H, Larsen B, Lin Z-Y, Breitkreutz A, Mellacheruvu D, Fermin D, Qin ZS, Tyers M, Gingras A-C, Nesvizhskii AI. 2011. SAINT: probabilistic scoring of affinity purification–mass spectrometry data. Nat Methods 8:70–73. doi: 10.1038/nmeth.1541. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Schäffer AA, Aravind L, Madden TL, Shavirin S, Spouge JL, Wolf YI, Koonin EV, Altschul SF. 2001. Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. Nucleic Acids Res 29:2994–3005. doi: 10.1093/nar/29.14.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Tatusova T, DiCuccio M, Badretdin A, Chetvernin V, Nawrocki EP, Zaslavsky L, Lomsadze A, Pruitt KD, Borodovsky M, Ostell J. 2016. NCBI prokaryotic genome annotation pipeline. Nucleic Acids Res 44:6614–6624. doi: 10.1093/nar/gkw569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Shell SS, Wang J, Lapierre P, Mir M, Chase MR, Pyle MM, Gawande R, Ahmad R, Sarracino DA, Ioerger TR, Fortune SM, Derbyshire KM, Wade JT, Gray TA. 2015. Leaderless transcripts and small proteins are common features of the mycobacterial translational landscape. PLoS Genet 11:e1005641. doi: 10.1371/journal.pgen.1005641. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Chong YH, Jung JM, Choi W, Park CW, Choi KS, Suh YH. 1994. Bacterial expression, purification of full length and carboxyl terminal fragment of Alzheimer amyloid precursor protein and their proteolytic processing by thrombin. Life Sci 54:1259–1268. doi: 10.1016/0024-3205(94)00853-1. [DOI] [PubMed] [Google Scholar]
- 73.Darwin AJ, Miller VL. 2001. The psp locus of Yersinia enterocolitica is required for virulence and for growth in vitro when the Ysc type III secretion system is produced. Mol Microbiol 39:429–444. doi: 10.1046/j.1365-2958.2001.02235.x. [DOI] [PubMed] [Google Scholar]
- 74.Garbe TR, Barathi J, Barnini S, Zhang Y, Abou-Zeid C, Tang D, Mukherjee R, Young DB. 1994. Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology 140:133–138. doi: 10.1099/13500872-140-1-133. [DOI] [PubMed] [Google Scholar]
- 75.Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, Bansal GP, Young JF, Lee MH, Hatfull GF. 1991. New use of BCG for recombinant vaccines. Nature 351:456–460. doi: 10.1038/351456a0. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.